Weight-Loss Drug Giant Eli Lilly Bets Big Again. Spending $7.8 Billion to Acquire Centessa, Is Now a Good Time to Buy Eli Lilly?
TradingKey - On March 31, Eastern Time, Eli Lilly officially announced its acquisition of U.S.-listed Centessa Pharmaceuticals for a total consideration of $7.8 billion, with the transaction expected to close in the third quarter of 2026. Following the news, Eli Lilly shares rose approximately 3% on Tuesday, while Centessa shares surged 45%.